Paper42246346
Beyond the scalpel: rare and experimental nonsurgical treatments for basal cell carcinoma.
Deng E and 1 other. Dermatol Online J, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Beyond the scalpel: rare and experimental nonsurgical treatments for basal cell carcinoma. Papers, record 42246346. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42246346
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Beyond the scalpel: rare and experimental nonsurgical treatments for basal cell carcinoma.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Basal Cell Carcinoma | Major topic |
| Skin Neoplasms | Major topic |
| Humans | |
| Antineoplastic Agents | |
| Curettage | |
| Mohs Surgery | |
| Imiquimod |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29782900 | Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. | J Am Acad Dermatol | 2019 | https://conductscience.org/library/papers/29782900 | PubMed |
| 2 | 29331385 | Guidelines of care for the management of basal cell carcinoma. | J Am Acad Dermatol | 2018 | https://conductscience.org/library/papers/29331385 | PubMed |
| 3 | 36728062 | Deep Shave Removal of Suspected Basal Cell Carcinoma: A Prospective Study. | Dermatol Surg | 2023 | https://conductscience.org/library/papers/36728062 | PubMed |
| 4 | 34845465 | A guide to curettage and cautery in the management of skin lesions. | Aust J Gen Pract | 2021 | https://conductscience.org/library/papers/34845465 | PubMed |
| 6 | 31106008 | Nonsurgical Options for the Treatment of Basal Cell Carcinoma. | Dermatol Pract Concept | 2019 | https://conductscience.org/library/papers/31106008 | PubMed |
| 7 | 26097726 | Advances in the management of basal cell carcinoma. | F1000Prime Rep | 2015 | https://conductscience.org/library/papers/26097726 | PubMed |
| 8 | 30096105 | Review of Common Alternative Herbal "Remedies" for Skin Cancer. | Dermatol Surg | 2019 | https://conductscience.org/library/papers/30096105 | PubMed |
| 9 | 37013127 | Efficacy and safety of 0.05% ingenol mebutate in the treatment of basal cell carcinoma: A prospective study. | Skin Health Dis | 2023 | https://conductscience.org/library/papers/37013127 | PubMed |
| 10 | 40149326 | Basal Cell Carcinoma: An Old Friend with Multiple Faces. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40149326 | PubMed |
| 11 | 25643667 | Management of high-risk and advanced basal cell carcinoma. | Clin Transl Oncol | 2015 | https://conductscience.org/library/papers/25643667 | PubMed |
| 13 | 12472348 | Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer. | Arch Dermatol | 2002 | https://conductscience.org/library/papers/12472348 | PubMed |
| 14 | 18173610 | Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study. | Int J Dermatol | 2008 | https://conductscience.org/library/papers/18173610 | PubMed |
| 15 | 1913614 | Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides. | Cancer Lett | 1991 | https://conductscience.org/library/papers/1913614 | PubMed |
| 16 | 24214835 | Topical application of St. John's wort (Hypericum perforatum). | Planta Med | 2014 | https://conductscience.org/library/papers/24214835 | PubMed |
| 17 | 21375515 | The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers. | Br J Dermatol | 2011 | https://conductscience.org/library/papers/21375515 | PubMed |
| 18 | 18179625 | Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study. | Photochem Photobiol | 2008 | https://conductscience.org/library/papers/18179625 | PubMed |
| 19 | 12600419 | Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. | Cancer Detect Prev | 2003 | https://conductscience.org/library/papers/12600419 | PubMed |
| 20 | 12756587 | The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis. | Arch Dermatol Res | 2003 | https://conductscience.org/library/papers/12756587 | PubMed |
| 21 | 28793140 | Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial. | JAMA Dermatol | 2017 | https://conductscience.org/library/papers/28793140 | PubMed |
| 22 | 20500542 | Temporary arrest of basal cell carcinoma formation in a patient with basal cell naevus syndrome (BCNS) since treatment with a gel containing various plant extracts. | J Eur Acad Dermatol Venereol | 2011 | https://conductscience.org/library/papers/20500542 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42246346
GET https://conductscience.org/api/papers/v1/42246346/references?page=2